These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 4975330)
41. [Problems of children with hemolytic disease of the newborn, caused by Rh and ABO blood group incompatibility, treated by exchange transfusion]. Osuch-Jaczewska R; Boruta E; Baumert M; Paprotny M; Jerzykiewicz-Dziuba K; Giec-Fuglewicz G Acta Haematol Pol; 1988; 19(3-4):153-9. PubMed ID: 3150889 [No Abstract] [Full Text] [Related]
42. [Hemolytic disease of the newborn caused by incompatibility between mother and child of Rh and ABO blood types]. Ogawa T Kango; 1966 Jul; 18(7):31-4. PubMed ID: 4958717 [No Abstract] [Full Text] [Related]
43. [Feto-maternal immunization with alloantigens HL-A and ABO, Rh antigens in pregnant women]. Zdebski Z Ginekol Pol; 1975 Feb; 46(2):219-23. PubMed ID: 803339 [No Abstract] [Full Text] [Related]
44. [Fetal erythroblastosis from the standpoint of a fetal disease]. Shirakawa K Sanfujinka No Jissai; 1971 Sep; 20(10):926-33. PubMed ID: 5000576 [No Abstract] [Full Text] [Related]
45. [Maternal-fetal blood group incompatibility in the light of recent statistical and immunohematological data]. Ragonese P; Rizzo F; Ricevuto C; D'Angelo S; Liotti B Minerva Ginecol; 1976 Jan; 28(1):26-30. PubMed ID: 815851 [No Abstract] [Full Text] [Related]
46. [Fetal-maternal leakage as 1 of the causes of the pathogenesis of hemolytic disease in the newborn]. Dziekan L Przegl Lek; 1971; 27(2):196-9. PubMed ID: 4994371 [No Abstract] [Full Text] [Related]
47. [Prevention of anti Rh immunization]. Pinon F Sem Hop; 1969 Sep; 45(37):2328-33. PubMed ID: 4187740 [No Abstract] [Full Text] [Related]
48. [1st attempts of prevention of rhesus isoimmunization]. Lepage F; Poulain M; Ravina JH Gynecol Obstet (Paris); 1969; 68(3):229-35. PubMed ID: 4187685 [No Abstract] [Full Text] [Related]
49. The use of blood groups in the study of populations. Mourant AE Ann N Y Acad Sci; 1970 Feb; 169(1):194-8. PubMed ID: 4984254 [No Abstract] [Full Text] [Related]
50. [Rh-antibodies in women receiving preventive treatment against Rh-immunization. Experiences after 2 years preventive program]. Orjasaeter H Tidsskr Nor Laegeforen; 1972 Dec; 92(35):2412-4. PubMed ID: 4120943 [No Abstract] [Full Text] [Related]
51. EFFECT OF ABO INCOMPATIBILITY ON PREGNANCY-INDUCED RH ISOIMMUNIZATION. DONOHUE WL; WAKE EJ Can Med Assoc J; 1964 Jan; 90(1):1-5. PubMed ID: 14105011 [TBL] [Abstract][Full Text] [Related]
52. [Massive feto-maternal and materno-fetal hemorrhage]. Valbonesi M; Cinollo G; Rivabella L; Serra G Minerva Pediatr; 1978 Jul; 30(14):1149-52. PubMed ID: 97508 [No Abstract] [Full Text] [Related]
53. [Current data and contribution to the study of hemolytic disease caused by feto-maternal blood incompatibility]. Trifan N; Lupaşcu G; Trifan E Rev Med Chir Soc Med Nat Iasi; 1971; 75(4):1049-54. PubMed ID: 4135203 [No Abstract] [Full Text] [Related]
58. [Present status of the prevention of hemolytic disease of the newborn due to Rh factors incompatibility]. de Sousa JS Rev Port Pediatr Pueric; 1969; 32(3):70-6. PubMed ID: 4185738 [No Abstract] [Full Text] [Related]
59. [Fetomaternal transfusion, Rhesus immunization and prevention. II. Rhesus immunization and prevention]. Helderweirt G Verh K Acad Geneeskd Belg; 1976; 38(3-4):79-134. PubMed ID: 826036 [No Abstract] [Full Text] [Related]
60. Maternofetal transfusion during delivery and RH-sensitisation of the newborn. Hindemann P Lancet; 1973 Jan; 1(7793):46. PubMed ID: 4118571 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]